DOP2002000422A - Agentes antibacterianos. - Google Patents
Agentes antibacterianos.Info
- Publication number
- DOP2002000422A DOP2002000422A DO2002000422A DO2002000422A DOP2002000422A DO P2002000422 A DOP2002000422 A DO P2002000422A DO 2002000422 A DO2002000422 A DO 2002000422A DO 2002000422 A DO2002000422 A DO 2002000422A DO P2002000422 A DOP2002000422 A DO P2002000422A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- formula
- antibacterial agents
- compounds
- useful
- preparing compounds
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29924901P | 2001-06-19 | 2001-06-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2002000422A true DOP2002000422A (es) | 2002-12-30 |
Family
ID=23153973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2002000422A DOP2002000422A (es) | 2001-06-19 | 2002-06-19 | Agentes antibacterianos. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1401830A2 (fr) |
| JP (1) | JP2005501021A (fr) |
| AU (1) | AU2002302894A1 (fr) |
| BR (1) | BR0210028A (fr) |
| CA (1) | CA2446963A1 (fr) |
| DO (1) | DOP2002000422A (fr) |
| GT (1) | GT200200104A (fr) |
| HN (1) | HN2002000150A (fr) |
| MX (1) | MXPA03009894A (fr) |
| PA (1) | PA8548401A1 (fr) |
| PE (1) | PE20030272A1 (fr) |
| SV (1) | SV2003001089A (fr) |
| WO (1) | WO2002102793A2 (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2538420A1 (fr) * | 2003-09-12 | 2005-03-24 | Warner-Lambert Company Llc | Agents antibacteriens a base de quinolone |
| WO2005049605A1 (fr) * | 2003-11-18 | 2005-06-02 | Warner-Lambert Company Llc | Derives antibacteriens d'aminoquinazolidinedione |
| WO2012088266A2 (fr) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Imidazopyridazines et benzimidazoles substitués en tant qu'inhibiteurs de fgfr3 |
| EP2686305B1 (fr) | 2011-03-14 | 2020-09-16 | Impact Therapeutics, Inc. | Quinazolinediones et leur utilisation |
| TWI527800B (zh) * | 2011-04-01 | 2016-04-01 | 南京英派藥業有限公司 | 作為聚（二磷酸腺苷酸－核醣）聚合酶（ｐａｒｐ）之抑制劑之１－（芳基甲基）喹唑啉－２，４（１ｈ，３ｈ）－二酮及其應用 |
| US9611267B2 (en) | 2012-06-13 | 2017-04-04 | Incyte Holdings Corporation | Substituted tricyclic compounds as FGFR inhibitors |
| US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| TWI649318B (zh) | 2013-04-19 | 2019-02-01 | 英塞特控股公司 | 作為ｆｇｆｒ抑制劑之雙環雜環 |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| WO2016134294A1 (fr) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| AU2016219822B2 (en) | 2015-02-20 | 2020-07-09 | Incyte Holdings Corporation | Bicyclic heterocycles as FGFR inhibitors |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| CL2015003780A1 (es) | 2015-12-30 | 2016-09-16 | Univ Chile | Compuestos derivados pirimido-isoquinolin-quinonas, sus sales, isomeros, tautomeros farmacéuticas aceptables; composiciones farmáceuticas; procedimiento de preparación; y su uso en el tratamiento de enfermedades bacterianas y bacterianas multirresistentes. |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| CA3091292A1 (fr) | 2018-02-16 | 2019-08-22 | Sunovion Pharmaceuticals Inc. | Sels, formes cristallines et procedes de production associes |
| TW201946630A (zh) | 2018-05-04 | 2019-12-16 | 美商英塞特公司 | Fgfr抑制劑之鹽 |
| ES2991427T3 (es) | 2018-05-04 | 2024-12-03 | Incyte Corp | Formas sólidas de un inhibidor de FGFR y procedimientos para preparar las mismas |
| CN111620866A (zh) * | 2019-02-27 | 2020-09-04 | 南京药石科技股份有限公司 | 一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法 |
| US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
| WO2021007269A1 (fr) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
| WO2021067374A1 (fr) | 2019-10-01 | 2021-04-08 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
| GEAP202415945A (en) | 2019-10-14 | 2024-04-25 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
| WO2021076728A1 (fr) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
| AU2020395185A1 (en) | 2019-12-04 | 2022-06-02 | Incyte Corporation | Derivatives of an FGFR inhibitor |
| CA3163875A1 (fr) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Heterocycles tricycliques en tant qu'inhibiteurs de fgfr |
| WO2021146424A1 (fr) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr |
| CN115734785A (zh) | 2020-04-14 | 2023-03-03 | 桑诺维恩药品公司 | (S)-(4,5-二氢-7H-噻吩并[2,3-c]吡喃-7-基)-N-甲基甲胺用于治疗神经和精神方面的病症 |
| EP4323405A1 (fr) | 2021-04-12 | 2024-02-21 | Incyte Corporation | Polythérapie comprenant un inhibiteur de fgfr et un agent de ciblage de nectine-4 |
| AR126101A1 (es) | 2021-06-09 | 2023-09-13 | Incyte Corp | Heterociclos tricíclicos como inhibidores de fgfr |
| CA3220274A1 (fr) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Heterocycles tricycliques en tant qu'inhibiteurs de fgfr |
| AR127404A1 (es) | 2021-10-20 | 2024-01-17 | Insilico Medicine Ip Ltd | Inhibidores de la metionina adenosiltransferasa 2a (mat2a) y usos de los mismos |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1311573A (en) * | 1970-04-27 | 1973-03-28 | Hisamitsu Pharmaceutical Co | Quinazolinedione derivatives |
| DE2334266A1 (de) * | 1972-07-07 | 1974-01-31 | Hisamitsu Pharmaceutical Co | Pyrido eckige klammer auf 2,3-d eckige klammer zu pyrimidin-2,4 (1h, 3h)-dione |
| JPS5758347B2 (fr) * | 1974-04-03 | 1982-12-09 | Hisamitsu Pharmaceutical Co | |
| JPS5761743B2 (fr) * | 1974-04-25 | 1982-12-25 | Hisamitsu Pharmaceutical Co | |
| DE2446543A1 (de) * | 1974-09-28 | 1976-04-15 | Hoechst Ag | Wasserunloesliche monoazomethinfarbstoffe, verfahren zu ihrer herstellung und ihre verwendung |
| DE2614148A1 (de) * | 1976-04-02 | 1977-10-20 | Henkel & Cie Gmbh | Oxidations-, bleich- und waschmittel mit einem gehalt an bleichaktivatoren |
| IT1228293B (it) * | 1989-02-06 | 1991-06-07 | Angeli Inst Spa | Benzoderivati di composti eterociclici contenenti azoto. |
| WO1994014809A1 (fr) * | 1992-12-23 | 1994-07-07 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Derives anneles d'uracile |
| JPH09208543A (ja) * | 1995-11-29 | 1997-08-12 | Ono Pharmaceut Co Ltd | イソシアナート誘導体およびその関連化合物の製造方 法 |
| EP0896961A4 (fr) * | 1995-12-28 | 1999-04-07 | Fuji Chem Ind Co Ltd | Procede de fabrication des derives de la 3-dihalobenzyl-2,4-quinazolinedione |
| US5780628A (en) * | 1996-02-01 | 1998-07-14 | Sumitomo Chemical Company, Limited | Process for producing dioxoquinazolines |
| JPH09295977A (ja) * | 1996-04-30 | 1997-11-18 | Terumo Corp | ピリドピリミジン誘導体及びそれを含有する医薬組成物 |
| WO1998018781A2 (fr) * | 1996-10-28 | 1998-05-07 | Versicor, Inc. | Banques combinatoires de 2,4-pyrimidinediones fusionnes et 2,4-pyrimidinediones fusionnes actifs biologiquement |
| AU9503998A (en) * | 1997-10-28 | 1999-05-17 | Warner-Lambert Company | Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents |
| OA12316A (en) * | 2000-01-24 | 2006-05-15 | Warner Lambert Co | 3-Aminoquinazolin-2,4-dione antibacterial agents. |
| US20030105118A1 (en) * | 2000-04-18 | 2003-06-05 | Shuji Masumoto | Tricyclic quinazolinediones |
| JP2002284699A (ja) * | 2001-03-28 | 2002-10-03 | Sumitomo Pharmaceut Co Ltd | 視細胞変性疾患治療剤 |
-
2002
- 2002-05-13 AU AU2002302894A patent/AU2002302894A1/en not_active Abandoned
- 2002-05-13 MX MXPA03009894A patent/MXPA03009894A/es unknown
- 2002-05-13 JP JP2003506266A patent/JP2005501021A/ja not_active Withdrawn
- 2002-05-13 WO PCT/IB2002/001768 patent/WO2002102793A2/fr not_active Ceased
- 2002-05-13 EP EP02730582A patent/EP1401830A2/fr not_active Withdrawn
- 2002-05-13 CA CA002446963A patent/CA2446963A1/fr not_active Abandoned
- 2002-05-13 BR BR0210028-2A patent/BR0210028A/pt not_active IP Right Cessation
- 2002-05-31 GT GT200200104A patent/GT200200104A/es unknown
- 2002-06-18 PE PE2002000523A patent/PE20030272A1/es not_active Application Discontinuation
- 2002-06-18 HN HN2002000150A patent/HN2002000150A/es unknown
- 2002-06-18 SV SV2002001089A patent/SV2003001089A/es unknown
- 2002-06-19 DO DO2002000422A patent/DOP2002000422A/es unknown
- 2002-06-19 PA PA20028548401A patent/PA8548401A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PA8548401A1 (es) | 2003-05-14 |
| AU2002302894A1 (en) | 2003-01-02 |
| HN2002000150A (es) | 2002-09-13 |
| MXPA03009894A (es) | 2004-02-17 |
| CA2446963A1 (fr) | 2002-12-27 |
| PE20030272A1 (es) | 2003-03-21 |
| GT200200104A (es) | 2003-02-11 |
| EP1401830A2 (fr) | 2004-03-31 |
| WO2002102793A3 (fr) | 2003-04-10 |
| BR0210028A (pt) | 2004-06-22 |
| WO2002102793A2 (fr) | 2002-12-27 |
| JP2005501021A (ja) | 2005-01-13 |
| SV2003001089A (es) | 2003-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2002000422A (es) | Agentes antibacterianos. | |
| UY27424A1 (es) | Agentes antidiabéticos | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| CR7332A (es) | INHIBIDORES DEL FACTOR Xa Y DE OTRAS PROTEASAS DE SERINA IMPLICADAS EN LA CASCADA DE LA COAGULACION | |
| UA88012C2 (uk) | Похідні хіназоліндіону як інгібітори parp | |
| UY27226A1 (es) | Pirazolopirimidinas como agentes terapéuticos | |
| ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
| UY27350A1 (es) | Azaindoles | |
| ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
| UY28671A1 (es) | Pirido(2.3-d)pirimidina-2,4-diaminas como inhibidores de pde 2 | |
| SE0400043D0 (sv) | New compounds | |
| ATE300541T1 (de) | Pyrazolopyridinderivate | |
| SE0302192D0 (sv) | Novel compounds | |
| SE0403171D0 (sv) | New compounds | |
| SE0302139D0 (sv) | Novel compounds | |
| PA8568101A1 (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso | |
| CR7956A (es) | Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos | |
| PA8589801A1 (es) | Aminoalcoxiindoles | |
| ATE373000T1 (de) | Pyrazolopyridin-derivate als antiherpesmittel | |
| ATE274515T1 (de) | Pyrazolopyridinderivate | |
| UY27514A1 (es) | Compuestos basicos lineales que tienen actividad antagonista de nk-2 y sus formulaciones. | |
| DOP2002000386A (es) | Agentes antibacterianos | |
| UY29999A1 (es) | "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones" | |
| SE0403118D0 (sv) | New compounds 2 | |
| HN2002000111A (es) | Agentes antibacterianos |